top of page
Transforming healthcare for people living with chronic conditions.
Introducing Kitea: the world's most accurate implantable sensor for hydrocephalus.
NEWS
Pressure-guided management of chronic disease.
Kitea enables early intervention and delivers better outcomes at every level, through the next generation of micro-implantable devices.
How it works
The Kitea system eliminates guesswork by enabling pressure monitoring at home and in hospital, for the first time.
Enable
Device is implanted during a simple procedure, designed for long-term use
Measure
Take pressure measurements in hospital or at home, and track symptoms
Manage
Physicians monitor measurements and set thresholds for portal notifications
Resolve
Physicians make informed decisions based on real pressure values
Hydrocephalus: from reactive to proactive care.
Caused by a buildup of excess fluid in the brain, hydrocephalus is a serious, lifelong condition.
The condition disproportionately affects children, and it is generally fatal without treatment. The main treatment path places a shunt in the brain to drain excess fluid and prevent a rise in pressure.
Shunt failure is common
Highest failure rate of any implanted medical device
Symptoms are confusing
Shunt failure can mimic common illnesses
Significant risks
Increase in intracranial pressure can be life threatening
Requires hospital admission
Assessment of failure is complex and expensive
A better way with Kitea.
Hydrocephalus: by the numbers
Improving outcomes at every level.
For patients
-
Reduced inequity in healthcare access
-
Monitor symptoms any time, any place
-
Early detection, less time in hospital
For hospitals
-
Estimated 30% reduction in costs
-
Fewer CT, MRI and other imaging procedures
-
Better clinical outcomes
For payers
-
Significant reduction in insurance costs
-
Better outcomes for patients
-
Reimbursement codes available for remote monitoring
Our accolades
Contact the team.
Sources: Hydrocephalus
1. Hydrocephalus Association; About Hydrocephalus
2. Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JR; Hydrocephalus Clinical Research Network. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr. 2008 Feb;1(2):131-7.
3. Reddy GK, Bollam P, Caldito G. Long-Term Outcomes of Ventriculoperitoneal Shunt Surgery in Patients with Hydrocephalus. World Neurosurgery. 2014;81(2):404-10.
4. Chern JJ, Macias CG, Jea A, Curry DJ, Luerssen TG, Whitehead WE. Effectiveness of a clinical pathway for patients with cerebrospinal fluid shunt malfunction. Journal of Neurosurgery: Pediatrics. 2010;6(4):318-24
5. Naftel RP, Tubergen E, Shannon CN, Gran KA, Vance EH, Oakes WJ, et al. Parental recognition of shunt failure: a prospective single-institution study. Journal of Neurosurgery: Pediatrics. 2012;9(4):363-71.
6. Barber, J.M., et al., Telemetric intra-cranial pressure monitoring: clinical and financial considerations. British Journal of Neurosurgery, 2017. 31(3): p. 300-306.
bottom of page